Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000405
Filing Date
2025-01-03
Accepted
2025-01-03 16:15:17
Documents
1
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 form4-01032025_040111.html 4  
1 form4-01032025_040111.xml 4 7867
  Complete submission text file 0001415889-25-000405.txt   9264
Mailing Address C/O ARSANIS, INC. 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address
Russo Rene (Reporting) CIK: 0001722066 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 25506386

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)